|
EsophyX™
 GERD is a disease that today
is typically treated with
proton pump inhibitors (PPIs).
Pharmaceutical therapies
like PPIs can lose their
effectiveness over time,
requiring progressively
higher dosing. Research
shows that of the
approximately 30 million
Americans diagnosed with
chronic GERD and dependent
on daily medications, 20-40%
are not satisfied with PPIs. In
addition, known side effects
of long-term use of PPIs
include osteomalacia
(inadequate absorption of
calcium and other minerals
into the bones). Recent case
studies on the adverse
effects of long-term PPI use
indicate a significantly
higher incidence of hip
fractures, particularly
among women.
The EsophyX™ Endoluminal
Fundoplication (ELF)
procedure is a surgical
procedure for the treatment
of reflux disease. The ELF
procedure is based on the
principles of surgical
repair of the
gastroesophageal junction
and is intended to deliver
similar benefits as the
time-proven laparoscopic
fundoplication. The ELF
procedure reconstructs an
anti-reflux barrier valve,
thus restoring the
gastroesophageal junction
back to what is believed to
be its natural anatomical
geometry.
Benefits:
- Effective, long-term solution to GERD
- Eliminates heartburn in over 85% of patients
- Gets 79% of patients off PPIs 2 years after the procedure
- No external incisions and no internal dissection minimizes patient discomfort and shortens recovery
- Clinical results are comparable to more invasive GERD surgical treatments like the Nissen procedure but with fewer side effects
- Allows for earlier intervention
- Improves quality of life score by 64% over PPIs
- Reduces hiatal hernia in 89% of patients
- Safe and atraumatic
- Customizable to patient's needs and can be revised if required
- Minimizes patient downtime. Most patient can return to work and normal activities in as little as one day
|
